AF
IBDX icon

Arrow Financial’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Arrow Financial’s Portfolio IBDX Stock Details IBDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.9M Buy
630,882
+16,370
+3% +$413K 1.42% 16
2026
Q1 		$15.5M Buy
614,512
+15,366
+3% +$392K 1.56% 13
2025
Q4 		$15.3M Buy
599,146
+22,170
+4% +$567K 1.52% 14
2025
Q3 		$14.8M Sell
576,976
-15,023
-3% -$381K 1.51% 14
2025
Q2 		$15M Sell
591,999
-5,192
-0.9% -$129K 1.58% 13
2025
Q1 		$14.9M Sell
597,191
-2,752
-0.5% -$68.1K 1.67% 11
2024
Q4 		$14.7M Buy
599,943
+14,943
+3% +$374K 1.4% 14
2024
Q3 		$15M Buy
585,000
+11,981
+2% +$303K 1.39% 14
2024
Q2 		$14.1M Buy
573,019
+18,130
+3% +$443K 1.37% 15
2024
Q1 		$13.8M Buy
554,889
+25,348
+5% +$628K 1.37% 15
2023
Q4 		$13.4M Buy
529,541
+68,783
+15% +$1.64M 1.39% 14
2023
Q3 		$10.8M Buy
460,758
+164,304
+55% +$3.97M 1.27% 24
2023
Q2 		$7.3M Buy
296,454
+105,489
+55% +$2.61M 0.88% 30
2023
Q1 		$4.79M Buy
+190,965
New +$4.73M 0.62% 42

Other funds holding IBDX

ACA
Aptus Capital Advisors Fairhope, Alabama $14.6B AUM 22.78% 1-Year Est. Return
CIA
Capital Investment Advisors Atlanta, Georgia $7.59B AUM 23.38% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CAI
Capital Advisors Inc Tulsa, Oklahoma $6.8B AUM 26.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SIC
Sigma Investment Counselors Northville, Michigan $2.05B AUM 18.42% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
KA
Klingman & Associates New York $2.35B AUM 23.18% 1-Year Est. Return

Arrow Financial's IBDX Position: Q2 2026 in Review

Arrow Financial increased its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 2.7% in Q2 2026, buying an estimated $413K and bringing the position to 630,882 shares worth $15.9M. The position accounts for 1.42% of the portfolio, ranked #16.

Arrow Financial first reported a position in IBDX in Q1 2023 and has held it in 14 quarters since. 228 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.

  • Arrow Financial held 630,882 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $15.9M as of Q2 2026.
  • Arrow Financial bought 16,370 iShares iBonds Dec 2032 Term Corporate ETF shares in Q2 2026, an estimated $413K.
  • iShares iBonds Dec 2032 Term Corporate ETF made up 1.42% of Arrow Financial's portfolio in Q2 2026, its #16 holding.
  • Arrow Financial first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q1 2023 and has held it in 14 quarters since.
  • 228 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.

Based on Arrow Financial's 13F filing for Q2 2026, filed 31 Jul 2026.